As of Sep 30
| +0.41 / +3.34%|
The 1 analysts offering 12-month price forecasts for Madrigal Pharmaceuticals Inc have a median target of 22.75, with a high estimate of 22.75 and a low estimate of 22.75. The median estimate represents a +79.42% increase from the last price of 12.68.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.